1. Home
  2. VSTM vs INN Comparison

VSTM vs INN Comparison

Compare VSTM & INN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSTM
  • INN
  • Stock Information
  • Founded
  • VSTM 2010
  • INN 2010
  • Country
  • VSTM United States
  • INN United States
  • Employees
  • VSTM N/A
  • INN N/A
  • Industry
  • VSTM Biotechnology: Pharmaceutical Preparations
  • INN Real Estate Investment Trusts
  • Sector
  • VSTM Health Care
  • INN Real Estate
  • Exchange
  • VSTM Nasdaq
  • INN Nasdaq
  • Market Cap
  • VSTM 581.6M
  • INN 584.3M
  • IPO Year
  • VSTM 2012
  • INN 2011
  • Fundamental
  • Price
  • VSTM $10.71
  • INN $5.46
  • Analyst Decision
  • VSTM Strong Buy
  • INN Sell
  • Analyst Count
  • VSTM 9
  • INN 2
  • Target Price
  • VSTM $13.38
  • INN $4.50
  • AVG Volume (30 Days)
  • VSTM 2.8M
  • INN 795.6K
  • Earning Date
  • VSTM 11-04-2025
  • INN 11-04-2025
  • Dividend Yield
  • VSTM N/A
  • INN 5.99%
  • EPS Growth
  • VSTM N/A
  • INN N/A
  • EPS
  • VSTM N/A
  • INN N/A
  • Revenue
  • VSTM $13,379,000.00
  • INN $727,443,000.00
  • Revenue This Year
  • VSTM $88.60
  • INN $1.16
  • Revenue Next Year
  • VSTM $416.99
  • INN $2.54
  • P/E Ratio
  • VSTM N/A
  • INN N/A
  • Revenue Growth
  • VSTM 33.79
  • INN N/A
  • 52 Week Low
  • VSTM $3.46
  • INN $3.57
  • 52 Week High
  • VSTM $11.25
  • INN $6.99
  • Technical
  • Relative Strength Index (RSI)
  • VSTM 65.97
  • INN 52.31
  • Support Level
  • VSTM $7.29
  • INN $4.84
  • Resistance Level
  • VSTM $10.45
  • INN $5.79
  • Average True Range (ATR)
  • VSTM 0.68
  • INN 0.21
  • MACD
  • VSTM 0.23
  • INN 0.01
  • Stochastic Oscillator
  • VSTM 93.53
  • INN 56.32

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

About INN Summit Hotel Properties Inc.

Summit Hotel Properties Inc is a U.S.-based hotel investment company focusing on select-service hotels in the upscale and upper-midscale properties in the U.S. Substantially all of Summit's assets are held and operated by its Operating Partnership, Summit Hotel OP, LP, in which the company holds general and limited partnership interests. The firm has one segment in activities related to investing in real estate. Summit's revenue streams include Room and Other hotel operations revenue. Room comprises the majority of total revenues. The firm's hotels are located in various markets, such as corporate offices, retail centers, airports, state capitols, convention centers, and leisure attractions. Summit's hotels operate under brands, including Marriott, Hilton, Hyatt, and Holiday Inn.

Share on Social Networks: